Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Abbott Wins FDA Approval for Aveir VR Mini, Its Smallest Leadless Pacemaker Yet

15 September 2026 · By · Wire by Fusion42

Published

15 September 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at mddionline.com →

◆ Verified

Fusion42 · 16 September 2026 · Fusion42 review

Abbott has received FDA approval for the Aveir VR Mini, the smallest leadless pacemaker to date, allowing expanded treatment options for patients needing ventricular pacing.

This Wire brief sits within Fusion42's coverage of Medtech.

◆ ◆ The Wire takeaway

You have a new benchmark for miniaturisation in leadless heart devices as Abbott is clearing the regulatory bar with the Aveir VR Mini. Move quickly if your product targets small-device cardiac implants because the FDA is signalling acceptance of smaller, less invasive pacing technology.

◆ Coverage

1 source · 15 Sep 2026

◆ Related on Wire

◆ Topics

Medtechfda-approvalleadless-pacemakercardiovascular-devicemedtechabbott